Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Research on the brain.

Virginia M-Y Lee1, John Q Trojanowski

  • 1Center for Neurodegenerative Disease Research, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. vmylee@mail.med.upenn.edu

Science of Aging Knowledge Environment : SAGE KE
|October 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.

Acta neuropathologica communications·2015
Same author

Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration.

Acta neuropathologica·2015
Same author

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2015
Same author

Erratum to: Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

Acta neuropathologica·2015
Same author

Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models.

PloS one·2015
Same author

Variants associated with Gaucher disease in multiple system atrophy.

Annals of clinical and translational neurology·2015

This report summarizes the 3rd International Workshop on Dementia with Lewy Bodies and Parkinson's Disease Dementia. Key findings covered clinicopathological correlations, therapies, genetics, and basic science research for these neurodegenerative diseases.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • The Movement Disorder Society sponsored the 3rd International Workshop on Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD).
  • This workshop convened experts to discuss advancements in DLB and PDD research.
  • DLB and PDD are progressive neurodegenerative disorders characterized by cognitive decline and motor symptoms.

Purpose of the Study:

  • To summarize key findings and research directions presented at the 2003 workshop.
  • To highlight advancements in understanding the clinicopathological basis of DLB and PDD.
  • To provide an overview of current therapeutic strategies, genetic factors, and basic science research relevant to DLB and PDD.

Main Methods:

  • Meeting report summarizing presentations from an international workshop.

Related Experiment Videos

  • Focus on clinicopathological correlations, therapeutic approaches, genetic studies, and fundamental research.
  • Information synthesized from expert discussions and research findings.

    • Main Results:

    • Presentations covered the complex relationship between clinical symptoms and pathological changes in DLB and PDD.
    • Therapeutic strategies, including pharmacological and non-pharmacological interventions, were discussed.
    • Genetic underpinnings and ongoing basic science research provided insights into disease mechanisms.

    Conclusions:

    • The workshop underscored the need for continued research into the clinicopathological correlations of DLB and PDD.
    • Advancements in understanding genetics and basic science are crucial for developing effective therapies.
    • Collaborative efforts are essential for tackling these challenging neurodegenerative conditions.